欧林生物：股东泰昌集团拟减持不超过1.4789%股份

Core Viewpoint - The major shareholder, Taichang Group Co., Ltd., plans to reduce its stake in Olin Bio by selling up to 6 million shares, which represents no more than 1.4789% of the company's total share capital, due to its own funding needs [1] Summary by Sections - Shareholder Reduction Plan - Taichang Group intends to sell its shares through centralized bidding or block trading based on market conditions [1] - The reduction period is set for three months starting 15 trading days after the announcement [1] - The selling price will be determined by the market price at the time of the sale [1]